Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males

Vaccine

Volumn 31, Issue 37, 2013, Pages 3849-3855

  Goldstone, Stephen E ^a   Jessen, Heiko ^b   Palefsky, Joel M ^c   Giuliano, Anna R ^d   Moreira, Edson D ^e   Vardas, Eftyhia ^f,g   Aranda, Carlos ^h   Hillman, Richard J ⁱ   Ferris, Daron G ^j   Coutlee, Francois ^k   Marshall, J Brooke ^l   Vuocolo, Scott ^l   Haupt, Richard M ^l   Guris, Dalya ^l   Garner, Elizabeth ^l  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b J2: Private Clinic for Infectious Diseases   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g LANCET LABORATORIES   (South Africa)

^h INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

ⁱ Sydney Sexual Health Centre   (Australia)

^j MEDICAL COLLEGE OF GEORGIA   (United States)

^k CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^l MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

HPV; Males; Men who have sex with men; Young

Indexed keywords

QUADRIVALENT WART VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ANUS CARCINOMA; ARTICLE; BIOPSY; DRUG EFFICACY; EXTERNAL GENITAL LESION; GENITAL SYSTEM DISEASE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNE DEFICIENCY; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PERSISTENT INFECTION; PRIORITY JOURNAL; SEROPREVALENCE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; TUMOR VIRUS; VACCINATION; WART VIRUS;

HPV; MALES; MEN WHO HAVE SEX WITH MEN; YOUNG;

ADOLESCENT; ADULT; ANAL CANAL; ANUS NEOPLASMS; GENITAL NEOPLASMS, MALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 6; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881544326     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.057     Document Type: Article

References (20)

1. World Health Organization Human papillomavirus infection and cervical cancer 2004, World Health Organization, available from, [accessed 05.07.07]. http://www.who.int/vaccine_research/diseases/hpv/en/.
2. Giuliano A.R., Lee J.H., Fulp W., Villa L.L., Lazcano E., Papenfuss M.R., et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011, 377:932-940.
3. Wiley D.J., Douglas J., Beutner K., Cox T., Fife K., Moscicki A.B., et al. External genital warts: diagnosis, treatment and prevention. Clinical Infectious Diseases 2002, 35:S210-S224.
4. Palefsky J.M. Human papillomavirus-related disease in men: not just a women's issue. Journal of Adolescent Health 2010, 46:S12-S19.
5. Giuliano A.R., Anic G., Nyitray A.G. Epidemiology and pathology of HPV disease in males. Gynecologic Oncology 2010, 117:S15-S19.
6. Chan P.K., Ho W.C., Yu M.Y., Pong W.M., Chan A.C., Chan A.K., et al. Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades. International Journal of Cancer 2009, 125:1671-1677.
7. Aubin F., Pretet J.L., Jacquard A.C., Saunier M., Carcopino X., Jaroud F., et al. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clinical Infectious Diseases 2008, 47:610-615.
8. Anic G.M., Lee J.H., Stockwell H., Rollison D.E., Wu Y., Papenfuss M.R., et al. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. Journal of Infectious Diseases 2011, 204:1886-1892.
9. Muñoz N., Castellsague X., de Gonzalez A.B., Gissman L. HPV in the etiology of human cancer. Vaccine 2006, 24:S1-S10.
10. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens-part B: biological agents. Lancet Oncology 2009, 10:321-322.
11. Wheeler C., Kjaer S.K., Sigurdsson K., Iversen O., Hernandez-Avila M., Perez G., et al. The impact of quadrivalent HPV (type 6/11/16/18) L1 VLP vaccine on infection and disease due to oncogenic non-vaccine HPV types in sexually active women aged 16-26. Journal of Infectious Diseases 2009, 199:936-944.
12. Brown D.R., Kjaer S.K., Sigurdsson K., Iversen O-E., Hernandez-Avila M., Wheeler C.M., et al. The impact of quadrivalent HPV (type 6/11/16/18) L1 VLP vaccine on infection and disease due to oncogenic non-vaccine HPV types in generally HPV naive women aged 16-26. Journal of Infectious Diseases 2009, 199:926-935.
13. Giuliano A.R., Palefsky J.M., Goldstone S., Moreira E.D., Penny M.E., Aranda C., et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. New England Journal of Medicine 2011, 364:401-411.
14. Henry M.R. The Bethesda system 2001: an update of new terminology for gynecologic cytology. Clinics in Laboratory Medicine 2003, 23:585-603.
15. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine 2007, 356:1928-1943.
16. The FUTURE II Study Group Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New England Journal of Medicine 2007, 356:1915-1927.
17. Weaver B.A., Feng Q., Holmes K.K., Kiviat N., Lee S.K., Meyer C., et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. Journal of Infectious Diseases 2004, 189:677-685.
18. Vardas E., Giuliano A., Goldstone Palefsky J., Moreira E.D., Penny M.E., et al. External genital HPV prevalence and associated factors among heterosexual men on five continents. Journal of Infectious Diseases 2010, 203:58-65.
19. Goldstone S.E., Palefsky J., Giuliano A., Moreira E.D., Aranda C., Jessen H., et al. Prevalence and risk factors for HPV infection in HIV seronegative men who have sex with men. Journal of Infectious Diseases 2010, 203:66-74.
20. Palefsky J.M., Giuliano A.R., Goldstone S., Moreira E.D., Aranda C., Jessen H., et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. New England Journal of Medicine 2011, 365:1576-1585.